Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Immucell (ICCC) Shares Issued (2017 - 2025)

Immucell's Shares Issued history spans 16 years, with the latest figure at $349323.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 92.48% year-over-year to $349323.0; the TTM value through Dec 2025 reached $349326.0, down 93.32%, while the annual FY2025 figure was $349326.0, 92.48% down from the prior year.
  • Shares Issued reached $349323.0 in Q4 2025 per ICCC's latest filing, up from -$19431.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.6 million in Q4 2024 to a low of -$26.7 million in Q2 2021.
  • Average Shares Issued over 5 years is -$1.6 million, with a median of $11680.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: crashed 12836.18% in 2021, then soared 17023.29% in 2023.
  • A 5-year view of Shares Issued shows it stood at -$4.2 million in 2021, then surged by 100.0% to -$2.0 in 2022, then skyrocketed by 50000100.0% to $1.0 million in 2023, then skyrocketed by 364.8% to $4.6 million in 2024, then crashed by 92.48% to $349323.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Shares Issued are $349323.0 (Q4 2025), -$19431.0 (Q2 2025), and $19434.0 (Q1 2025).